ALGS (ALIGOS THERAPEUTICS INC) — 3 tracked funds

Cross-fund · 3 holders

ALGS

ALIGOS THERAPEUTICS INC

CUSIP 01626L204

Tracked holders

$2.4M

Aggregate value

267,746

Active funds

Funds holding ALGS

Fund	Strategy	Period	Value	% of book	Δ shares	Status
Vanguard	Institutional	Q4 2025	$1.9M	—	+28,706	+16.7%
Citadel	Multi-Strategy	Q1 2026	$403,531	—	+2,477	+4.8%
BlackRock	Institutional	Q1 2026	$96,887	—	0	HELD

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.